A Phase 3 Multi-Center Open-Label Study to Assess the DiagNostic
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
This is a phase 3, multi-center, open-label, single-arm, non-randomized study to evaluate the diagnostic performance and safety of 18F-DCFPyL (PyL) PET/CT in subjects with suspected recurrence of prostate cancer and negative or equivocal findings per institutional standard of care conventional imaging.
Details
| Condition | TBD |
|---|---|
| Age | 99years or below |
| Clinical Study Identifier | 03739684 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.